U:  P:        Forgot Password? Username?
Asthma
A Study of Xolair in Subjects With Moderate to Severe Persistent Asthma (EXTRA) PDF Print E-mail
  • This is a multicenter, randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of subcutaneously administered Xolair as add-on therapy to high-dose ICS+LABA for the treatment of subjects aged 12-75 years old diagnosed with moderate to severe asthma who are inadequately controlled with high-dose ICS+LABA.
 
A Comparison of SYMBICORT pMDI With Budesonide HFA pMDI in African American Subjects With Asthma. PDF Print E-mail
  • The purpose of this study is to determine the effectiveness and safety of SYMBICORT® pMDI (a medication approved by the Food and Drug Administration, FDA) in the African American population.
 


Privacy PolicyTerms of ServiceLogin